AesRx
275 Grove Street
Suite 2-400
Newton
Massachusetts
02466
United States
Tel: 617-965-2521
Fax: 617-963-7389
Website: http://www.aesrx.com/
Email: info@aesrx.com
10 articles about AesRx
-
Baxter International, Inc. Snags Orphan Drug-Focused Biopharma, AesRx For Undisclosed Amount
7/9/2014
-
AesRx Presents Phase 1/2a Trial Data Of Anti-Sickling Agent Aes-103 At American Society of Hematology
12/9/2013
-
AesRx Anti-Sickling Drug Aes-103 Begins Phase 2 Trial
9/3/2013
-
AesRx to Present Phase 1 Data on Anti-Sickling Agent Aes-103 at American Society of Hematology
11/27/2012
-
AesRx Anti-Sickling Drug Aes-103 Enters Phase 1/2a Clinical Trial at National Institutes of Health (NIH)
5/14/2012
-
AesRx Begins Clinical Trial of AES-103 for Sickle Cell Disease
12/6/2011
-
AesRx Announces Collaboration With National Institutes of Health (NIH) to Develop Aes-103 for Sickle Cell Disease
11/16/2010
-
Professor Henry Louis Gates, Jr., Joins AesRx Strategic Advisory Board
6/1/2010
-
AesRx Appoints Jordan, CMO of Sickle Cell Disease Association of America, to Clinical Advisory Board
2/25/2010
-
Former Idera Pharmaceuticals, Inc. CEO at Helm of AesRx, New Startup With Sickle Cell Drug
1/5/2010